This website uses cookies

This websites contains videos from YouTube. This company uses cookies (third party cookies). If you do not want them to use these cookies, you can indicate so here. However, this does mean that you will not be able to watch videos on this website. We also make use of our own cookies in order to improve our website. We don't share our data with other parties. Which cookies are involved?

This website uses cookies to enable video and to improve the user experience. If you do not want to accept these cookies, indicate so here. Which cookies are involved?

Ga direct naar de inhoud, het hoofdmenu, het servicemenu of het zoekveld.


21Jan 2019

Back to News overview

Brain tumor requires combination therapy

Promotie Gooijer NKI

Malignant brain tumors respond very poorly to treatment because of uncontrolled cell proliferation, strong invasiveness and resistance to therapy. PhD researcher Mark de Gooijer has shown that, although new treatments can efficiently attack each of these problems separately, combining them will be necessary to provide better prognoses for patients with brain tumors. On Wednesday he will defend his thesis. Good Luck Mark!

When: Wednesday January 23rd, 2.30 PM

Where: Academiegebouw, Domplein 29, 3512 JE Utrecht

Thesis title: Mounting an attack on the glioblastoma triad: proliferation, invasion and resistance.

More information about the defense.

Share this page